Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Insights into the Roles of lncRNAs as Modulators of Cytoskeleton Architecture and Their Implications in Cellular Homeostasis and in Tumorigenesis. | Noncoding RNA | 2022 | 35447891 | PubTator, text mining | PubMed |
| Identification of EMT-Related lncRNAs as Potential Prognostic Biomarkers and Therapeutic Targets for Pancreatic Adenocarcinoma. | J Oncol | 2022 | 35444701 | PubTator, text mining | PubMed |
| Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects. | Front Immunol | 2022 | 35444652 | PubTator, text mining | PubMed |
| Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma. | BMC Cancer | 2022 | 35443674 | PubTator, text mining | PubMed |
| Involvement of blood lncRNA UCA1 in sepsis development and prognosis, and its correlation with multiple inflammatory cytokines. | J Clin Lab Anal | 2022 | 35441408 | PubTator, text mining | PubMed |
| Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis. | Bioengineered | 2022 | 35435130 | PubTator, text mining | PubMed |
| A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/β‑catenin signaling pathway. | PeerJ | 2022 | 35433119 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network. | J Oncol | 2022 | 35432537 | PubTator, text mining | PubMed |
| Editorial: Clinical Genome Sequencing: Bioinformatics Challenges and Key Considerations. | Front Genet | 2022 | 35432455 | PubTator, text mining | PubMed |
| Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma. | Front Genet | 2022 | 35432441 | PubTator, text mining | PubMed |
| Long Non-Coding RNA NR-133666 Promotes the Proliferation and Migration of Fibroblast-Like Synoviocytes Through Regulating the miR-133c/MAPK1 Axis. | Front Pharmacol | 2022 | 35431959 | PubTator, text mining | PubMed |
| LINC00667 regulates MPP+ -induced neuronal injury in Parkinson's disease. | Ann Clin Transl Neurol | 2022 | 35426258 | PubTator, text mining | PubMed |
| Long non-coding RNA UCA1 promotes retinoblastoma progression by modulating the miR-124/c-myc axis. | Am J Transl Res | 2022 | 35422898 | PubTator, text mining | PubMed |
| Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics. | BMC Cancer | 2022 | 35418066 | PubTator, text mining | PubMed |
| Significant reduction of long non-coding RNAs expression in bipolar disorder. | BMC Psychiatry | 2022 | 35410190 | PubTator, text mining | PubMed |
| Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. | Cancers (Basel) | 2022 | 35406495 | PubTator, text mining | PubMed |
| Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma. | Cancer Sci | 2022 | 35403343 | PubTator, text mining | PubMed |
| Immune-Related lncRNAs Pairs to Construct a Novel Signature for Predicting Prognosis in Gastric Cancer. | Front Surg | 2022 | 35402492 | PubTator, text mining | PubMed |
| CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway. | Mol Ther Oncolytics | 2022 | 35399607 | PubTator, text mining | PubMed |
| Retraction notice to "Silence of long non-coding RNA UCA1 inhibits hemangioma cells growth, migration and invasion by up-regulation of miR-200c" [Life Sciences 226 (2019) 33-46]. | Life Sci | 2022 | 35396135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=47